Comments
Loading...
Biohaven Analyst Ratings and Price Targets | NYSE:BHVN | Benzinga
Biohaven Ltd has a consensus price target of $68.65 based on the ratings of 18 analysts. The high is $148.5 issued by Wedbush on August 8, 2022. The low is $24 issued by SVB Leerink on January 24, 2023. The 3 most-recent analyst ratings were released by Baird, Morgan Stanley, and JP Morgan on April 28, 2025, March 7, 2025, and March 5, 2025, respectively. With an average price target of $62.67 between Baird, Morgan Stanley, and JP Morgan, there's an implied 162.81% upside for Biohaven Ltd from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Baird
Morgan Stanley
JP Morgan
HC Wainwright & Co.
RBC Capital
1calculated from analyst ratings
Analyst Ratings for Biohaven
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/28/2025 | Buy Now | 139.04% | Baird | Brian Skorney44% | $60 → $57 | Maintains | Outperform | Get Alert |
| 03/07/2025 | Buy Now | 164.21% | Morgan Stanley | Terence Flynn67% | $69 → $63 | Maintains | Overweight | Get Alert |
| 03/05/2025 | Buy Now | 185.18% | JP Morgan | Tessa Romero59% | $72 → $68 | Maintains | Overweight | Get Alert |
| 03/04/2025 | Buy Now | 126.46% | HC Wainwright & Co. | Douglas Tsao52% | $54 → $54 | Reiterates | Buy → Buy | Get Alert |
| 03/04/2025 | Buy Now | 155.82% | RBC Capital | Leonid Timashev39% | $61 → $61 | Reiterates | Outperform → Outperform | Get Alert |
| 02/11/2025 | Buy Now | 172.59% | Deutsche Bank | David Hoang35% | → $65 | Initiates | → Buy | Get Alert |
| 12/17/2024 | Buy Now | — | Cantor Fitzgerald | Charles Duncan69% | — | Reiterates | Overweight → Overweight | Get Alert |
| 12/17/2024 | Buy Now | 147.43% | HC Wainwright & Co. | Douglas Tsao52% | $59 → $59 | Reiterates | Buy → Buy | Get Alert |
| 12/04/2024 | Buy Now | 155.82% | RBC Capital | Leonid Timashev39% | $58 → $61 | Reiterates | Outperform → Outperform | Get Alert |
| 11/26/2024 | Buy Now | 147.43% | HC Wainwright & Co. | Douglas Tsao52% | $59 → $59 | Reiterates | Buy → Buy | Get Alert |
| 11/25/2024 | Buy Now | 143.24% | RBC Capital | Leonid Timashev39% | $66 → $58 | Maintains | Outperform | Get Alert |
| 11/14/2024 | Buy Now | 147.43% | HC Wainwright & Co. | Douglas Tsao52% | $59 → $59 | Reiterates | Buy → Buy | Get Alert |
| 11/13/2024 | Buy Now | 214.53% | TD Cowen | Tyler Van Buren16% | $55 → $75 | Maintains | Buy | Get Alert |
| 11/13/2024 | Buy Now | 176.79% | RBC Capital | Leonid Timashev39% | $68 → $66 | Maintains | Outperform | Get Alert |
| 10/23/2024 | Buy Now | — | Cantor Fitzgerald | Charles Duncan69% | — | Reiterates | → Overweight | Get Alert |
| 10/04/2024 | Buy Now | — | Cantor Fitzgerald | Charles Duncan69% | — | Reiterates | → Overweight | Get Alert |
| 10/03/2024 | Buy Now | 185.18% | JP Morgan | Tessa Romero59% | $55 → $68 | Maintains | Overweight | Get Alert |
| 09/24/2024 | Buy Now | 176.79% | Bernstein | William Pickering39% | $55 → $66 | Maintains | Outperform | Get Alert |
| 09/24/2024 | Buy Now | 160.01% | B of A Securities | Jason Gerberry59% | $52 → $62 | Maintains | Buy | Get Alert |
| 09/24/2024 | Buy Now | 185.18% | RBC Capital | Leonid Timashev39% | $59 → $68 | Maintains | Outperform | Get Alert |
| 09/24/2024 | Buy Now | — | Cantor Fitzgerald | Charles Duncan69% | — | Reiterates | → Overweight | Get Alert |
| 09/24/2024 | Buy Now | 147.43% | HC Wainwright & Co. | Douglas Tsao52% | $59 → $59 | Reiterates | Buy → Buy | Get Alert |
| 09/23/2024 | Buy Now | 151.63% | Leerink Partners | Marc Goodman79% | $55 → $60 | Maintains | Outperform | Get Alert |
| 09/23/2024 | Buy Now | 218.73% | Piper Sandler | Christopher Raymond60% | $66 → $76 | Maintains | Overweight | Get Alert |
| 09/23/2024 | Buy Now | 151.63% | Baird | Brian Skorney44% | $58 → $60 | Maintains | Outperform | Get Alert |
| 09/16/2024 | Buy Now | 139.04% | Jefferies | Amy Li3% | → $57 | Initiates | → Buy | Get Alert |
| 09/04/2024 | Buy Now | 130.66% | Bernstein | William Pickering39% | → $55 | Initiates | → Outperform | Get Alert |
| 09/04/2024 | Buy Now | 147.43% | RBC Capital | Leonid Timashev39% | $59 → $59 | Reiterates | Outperform → Outperform | Get Alert |
| 08/19/2024 | Buy Now | — | Cantor Fitzgerald | Charles Duncan69% | — | Reiterates | → Overweight | Get Alert |
| 08/13/2024 | Buy Now | 126.46% | UBS | Ashwani Verma42% | $55 → $54 | Maintains | Buy | Get Alert |
| 08/12/2024 | Buy Now | — | Cantor Fitzgerald | Charles Duncan69% | — | Reiterates | → Overweight | Get Alert |
| 07/24/2024 | Buy Now | 143.24% | Morgan Stanley | Terence Flynn67% | → $58 | Initiates | → Overweight | Get Alert |
| 06/18/2024 | Buy Now | 147.43% | RBC Capital | Leonid Timashev39% | $59 → $59 | Reiterates | Outperform → Outperform | Get Alert |
| 05/30/2024 | Buy Now | 147.43% | HC Wainwright & Co. | Douglas Tsao52% | $59 → $59 | Reiterates | Buy → Buy | Get Alert |
| 05/30/2024 | Buy Now | — | Cantor Fitzgerald | Charles Duncan69% | — | Reiterates | → Overweight | Get Alert |
| 05/13/2024 | Buy Now | 147.43% | HC Wainwright & Co. | Douglas Tsao52% | $63 → $59 | Maintains | Buy | Get Alert |
| 04/23/2024 | Buy Now | 151.63% | UBS | Ashwani Verma42% | $59 → $60 | Maintains | Buy | Get Alert |
| 04/18/2024 | Buy Now | — | Cantor Fitzgerald | Charles Duncan69% | — | Reiterates | → Overweight | Get Alert |
| 04/10/2024 | Buy Now | — | Cantor Fitzgerald | Charles Duncan69% | — | Reiterates | → Overweight | Get Alert |
| 04/09/2024 | Buy Now | 155.82% | RBC Capital | Leonid Timashev39% | $61 → $61 | Reiterates | Outperform → Outperform | Get Alert |
| 03/04/2024 | Buy Now | 164.21% | HC Wainwright & Co. | Douglas Tsao52% | $50 → $63 | Maintains | Buy | Get Alert |
| 03/01/2024 | Buy Now | 155.82% | RBC Capital | Leonid Timashev39% | $62 → $61 | Maintains | Outperform | Get Alert |
| 03/01/2024 | Buy Now | 130.66% | TD Cowen | Tyler Van Buren16% | $35 → $55 | Maintains | Outperform | Get Alert |
| 02/23/2024 | Buy Now | 134.85% | JP Morgan | Tessa Romero59% | $32 → $56 | Maintains | Overweight | Get Alert |
| 02/16/2024 | Buy Now | 160.01% | RBC Capital | Leonid Timashev39% | → $62 | Initiates | → Outperform | Get Alert |
| 02/06/2024 | Buy Now | 147.43% | UBS | Ashwani Verma42% | → $59 | Initiates | → Buy | Get Alert |
| 12/22/2023 | Buy Now | 109.69% | HC Wainwright & Co. | Douglas Tsao52% | → $50 | Initiates | → Buy | Get Alert |
| 12/08/2023 | Buy Now | 143.24% | Baird | Brian Skorney44% | → $58 | Initiates | → Outperform | Get Alert |
| 11/20/2023 | Buy Now | 34.2% | JP Morgan | Tessa Romero59% | $26 → $32 | Maintains | Overweight | Get Alert |
| 11/15/2023 | Buy Now | 50.98% | Piper Sandler | Christopher Raymond60% | $29 → $36 | Maintains | Overweight | Get Alert |
| 08/16/2023 | Buy Now | 0.65% | JP Morgan | Tessa Romero59% | $27 → $24 | Maintains | Overweight | Get Alert |
| 07/17/2023 | Buy Now | 30.01% | Cantor Fitzgerald | Charles Duncan69% | → $31 | Reiterates | Overweight → Overweight | Get Alert |
| 06/06/2023 | Buy Now | 17.43% | BTIG | Thomas Shrader40% | $24 → $24 | Reiterates | → Buy | Get Alert |
| 04/04/2023 | Buy Now | 30.01% | Cantor Fitzgerald | Charles Duncan69% | $27 → $31 | Maintains | Overweight | Get Alert |
| 01/24/2023 | Buy Now | 0.65% | SVB Leerink | Marc Goodman79% | → $24 | Initiates | → Outperform | Get Alert |
| 01/04/2023 | Buy Now | -3.54% | JP Morgan | Tessa Romero59% | → $23 | Initiates | → Overweight | Get Alert |
| 12/02/2022 | Buy Now | 0.65% | BTIG | Thomas Shrader40% | → $24 | Initiates | → Buy | Get Alert |
| 10/26/2022 | Buy Now | -11.93% | Piper Sandler | Christopher Raymond60% | $23 → $21 | Maintains | Overweight | Get Alert |
| 10/12/2022 | Buy Now | -3.54% | Piper Sandler | Christopher Raymond60% | → $23 | Initiates | → Overweight | Get Alert |
| 08/19/2022 | Buy Now | — | Piper Sandler | Christopher Raymond60% | — | Downgrade | Overweight → Neutral | Get Alert |
| 08/08/2022 | Buy Now | 522.77% | Wedbush | Laura Chico35% | → $148.5 | Downgrade | Outperform → Neutral | Get Alert |
| 05/11/2022 | Buy Now | — | HC Wainwright & Co. | Douglas Tsao52% | — | Downgrade | Buy → Neutral | Get Alert |
| 05/11/2022 | Buy Now | 522.77% | Morgan Stanley | Jeffrey Hung13% | $146 → $148.5 | Maintains | Equal-Weight | Get Alert |
| 05/11/2022 | Buy Now | — | SVB Leerink | Marc Goodman79% | — | Downgrade | Outperform → Market Perform | Get Alert |
FAQ
What is the target price for Biohaven (BHVN) stock?
The latest price target for Biohaven (NYSE:BHVN) was reported by Baird on April 28, 2025. The analyst firm set a price target for $57.00 expecting BHVN to rise to within 12 months (a possible 139.04% upside). 36 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Biohaven (BHVN)?
The latest analyst rating for Biohaven (NYSE:BHVN) was provided by Baird, and Biohaven maintained their outperform rating.
When was the last upgrade for Biohaven (BHVN)?
There is no last upgrade for Biohaven
When was the last downgrade for Biohaven (BHVN)?
The last downgrade for Biohaven Ltd happened on August 19, 2022 when Piper Sandler changed their price target from N/A to N/A for Biohaven Ltd.
When is the next analyst rating going to be posted or updated for Biohaven (BHVN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Biohaven, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Biohaven was filed on April 28, 2025 so you should expect the next rating to be made available sometime around April 28, 2026.
Is the Analyst Rating Biohaven (BHVN) correct?
While ratings are subjective and will change, the latest Biohaven (BHVN) rating was a maintained with a price target of $60.00 to $57.00. The current price Biohaven (BHVN) is trading at is $23.85, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
